Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

TGF-β-related mechanisms of bone destruction in multiple myeloma.

Matsumoto T, Abe M.

Bone. 2011 Jan;48(1):129-34. doi: 10.1016/j.bone.2010.05.036. Epub 2010 Jun 1. Review.

PMID:
20570621
2.

Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.

Takeuchi K, Abe M, Hiasa M, Oda A, Amou H, Kido S, Harada T, Tanaka O, Miki H, Nakamura S, Nakano A, Kagawa K, Yata K, Ozaki S, Matsumoto T.

PLoS One. 2010 Mar 25;5(3):e9870. doi: 10.1371/journal.pone.0009870.

3.

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.

Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr.

Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27.

PMID:
18294945
4.

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.

Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S, Kido S, Inoue D, Matsumoto T.

Blood. 2005 Nov 1;106(9):3160-5. Epub 2005 Jul 19.

5.

Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells.

Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K.

EMBO J. 2004 Feb 11;23(3):552-63. Epub 2004 Jan 29.

6.
7.

Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis.

Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaissé JM, Foged NT.

J Biol Chem. 2002 Nov 15;277(46):44061-7. Epub 2002 Sep 10.

8.

Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretion.

Notsu M, Yamaguchi T, Okazaki K, Tanaka K, Ogawa N, Kanazawa I, Sugimoto T.

Endocrinology. 2014 Jul;155(7):2402-10. doi: 10.1210/en.2013-1818. Epub 2014 Apr 23.

PMID:
24758301
9.

[Mechanisms for formation of myeloma bone disease].

Yata K, Abe M, Matsumoto T.

Clin Calcium. 2008 Apr;18(4):438-46. doi: CliCa0804438446. Review. Japanese.

PMID:
18379024
10.
11.

Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development.

Matsunobu T, Torigoe K, Ishikawa M, de Vega S, Kulkarni AB, Iwamoto Y, Yamada Y.

Dev Biol. 2009 Aug 15;332(2):325-38. doi: 10.1016/j.ydbio.2009.06.002. Epub 2009 Jun 6.

12.

Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes.

Tang KT, Capparelli C, Stein JL, Stein GS, Lian JB, Huber AC, Braverman LE, DeVito WJ.

J Cell Biochem. 1996 Apr;61(1):152-66.

PMID:
8726364
13.

Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.

Atfi A, Lepage K, Allard P, Chapdelaine A, Chevalier S.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12110-4.

14.
15.

Transforming growth factor beta1, bone connection.

Kanaan RA, Kanaan LA.

Med Sci Monit. 2006 Aug;12(8):RA164-9. Epub 2006 Jul 12. Review.

PMID:
16865078
16.

Role of osteoblast suppression in multiple myeloma.

Stewart JP, Shaughnessy JD Jr.

J Cell Biochem. 2006 May 1;98(1):1-13. Review.

PMID:
16440324
17.

A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.

Andrades JA, Han B, Becerra J, Sorgente N, Hall FL, Nimni ME.

Exp Cell Res. 1999 Aug 1;250(2):485-98.

PMID:
10413602
18.

Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.

Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL.

Cancer Res. 2008 Mar 15;68(6):1809-19. doi: 10.1158/0008-5472.CAN-07-5597.

19.

PTH battles TGF-beta in bone.

Atfi A, Baron R.

Nat Cell Biol. 2010 Mar;12(3):205-7. doi: 10.1038/ncb0310-205.

PMID:
20190828
20.

Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.

Gebken J, Feydt A, Brinckmann J, Notbohm H, Müller PK, Bätge B.

J Endocrinol. 1999 Jun;161(3):503-10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk